Nomura Holdings’s Novo Nordisk NVO Stock Holding History

Nomura Holdings’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.1M	Buy	231,500 +156,500	+209%	+$6.72M	0.01%	512
2026 Q1	$2.76M	Buy	+75,000	New	+$3.55M	0.01%	821
2025 Q4	–	Sell	-42,000	Closed	-$2.33M	–	2084
2025 Q3	$2.33M	Sell	42,000 -50,000	-54%	-$2.93M	﹤0.01%	1082
2025 Q2	$6.35M	Sell	92,000 -608,000	-87%	-$41.4M	0.01%	509
2025 Q1	$48.6M	Buy	700,000 +685,000	+4,567%	+$56.6M	0.09%	144
2024 Q4	$1.29M	Buy	15,000 +8,700	+138%	+$941K	﹤0.01%	1328
2024 Q3	$750K	Buy	+6,300	New	+$840K	﹤0.01%	1183

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Nomura Holdings's NVO Position: Q2 2026 in Review

Nomura Holdings reduced its Novo Nordisk (NVO) stake by 32% in Q2 2026, selling an estimated $6.36M and leaving 314,926 shares worth $15.1M. The position accounts for 0.02% of the portfolio, ranked #437.

Nomura Holdings first reported a position in NVO in Q2 2013 and has held it in 19 quarters since. The position peaked at $54.1M in Q3 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Nomura Holdings held 314,926 shares of Novo Nordisk worth $15.1M as of Q2 2026.
Nomura Holdings sold 147,983 Novo Nordisk shares in Q2 2026, an estimated $6.36M.
Novo Nordisk made up 0.02% of Nomura Holdings's portfolio in Q2 2026, its #437 holding.
Nomura Holdings first reported a position in Novo Nordisk in Q2 2013 and has held it in 19 quarters since.
Nomura Holdings's Novo Nordisk position peaked at $54.1M in Q3 2025.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.